EVALUATING SHORT-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING

被引：0
|
作者：
Fan, C. S. [1 ]
Zhong, J. [2 ]
Sun, F. [3 ]
Liu, F. [3 ]
机构：
[1] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China
[2] Peking Univ, Beijing 100871, Peoples R China
[3] Novo Nordisk China Pharmaceut Co Ltd, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.812
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A162 / A163
页数：2
相关论文
共 50 条
  • [1] EVALUATING SHORT-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE VERSUS ORAL ANTIDIABETIC DRUGS IN PATIENTS WITH TYPE 2 DIABETES IN A CHINESE SETTING
    Shi, L. W.
    Han, S.
    Sun, F.
    Liu, F.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A163 - A163
  • [2] Evaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States
    Hunt, B.
    McConnachie, C. C.
    Gamble, C.
    Dang-Tan, T.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (11) : 1117 - 1120
  • [3] COST-EFFECTIVENESS ANALYSIS OF LIRAGLUTIDE VERSUS INSULIN GLARGINE IN CHINESE PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED ON METFORMIN
    Gu, X.
    Liu, F.
    Men, P.
    Zhai, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S75 - S75
  • [4] EVALUATING THE SHORT-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE VERSUS SITAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES FAILING METFORMIN MONOTHERAPY
    Langer, J.
    Hunt, B.
    Valentine, W. J.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A180 - A181
  • [5] EVALUATING THE COST-EFFECTIVENESS OF SWITCHING FROM INSULIN GLARGINE TO INSULIN DETEMIR IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING: A MODELING STUDY BASED ON THE PREDICTIVE STUDY
    Yang, L.
    Lay, A. L.
    Chang, J. H.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A97 - A97
  • [6] Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Failing Metformin Monotherapy in the United States
    Langer, Jakob
    Hunt, Barnaby
    Valentine, William J.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (03): : 237 - 246
  • [7] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [8] COST-EFFECTIVENESS OF EXENATIDE ONCE WEEKLY VERSUS INSULIN GLARGINE AND LIRAGLUTIDE FOR THE TREATMENT OF TYPE 2 DIABETES IN GREECE
    Tzanetakos, C.
    Bargiota, A.
    Kourlaba, G.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A672 - A672
  • [9] Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China
    James L. Palmer
    Amélie Beaudet
    Jeremy White
    Juliette Plun-Favreau
    Jayne Smith-Palmer
    [J]. Advances in Therapy, 2010, 27 : 814 - 827
  • [10] Cost-Effectiveness of Biphasic Insulin Aspart versus Insulin Glargine in Patients with Type 2 Diabetes in China
    Palmer, James L.
    Beaudet, Amelie
    White, Jeremy
    Plun-Favreau, Juliette
    Smith-Palmer, Jayne
    [J]. ADVANCES IN THERAPY, 2010, 27 (11) : 814 - 827
12345